stockportfolio.pro
Stocks / LNTH vs PCVX
LNTH vs PCVX
Lantheus Holdings, Inc. and Vaxcyte, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Lantheus Holdings, Inc. (LNTH) | Vaxcyte, Inc. (PCVX) | |
|---|---|---|
| Market cap | $6.5B | $6.8B |
| Revenue (latest FY) | $1.54B | $0 |
| Net income (latest FY) | $233.56M | $-766.63M |
| Revenue growth (5y CAGR) | 35.3% | — |
| Net margin | 15.2% | — |
| Return on equity | 21.4% | -28.5% |
| P/E ratio | 24.0 | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 7 | 0 |
| Positive free cash flow | Yes | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open LNTH — free Open PCVX — freeFrequently asked questions
Which is bigger, LNTH or PCVX?
Vaxcyte, Inc. is larger by market capitalization — $6.8B versus $6.5B.
Which grows faster, LNTH or PCVX?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.